Acquisitions Bullish 7

Hims & Hers Acquires Eucalyptus for $1.6B in Landmark Telehealth Consolidation

US telehealth giant Hims & Hers has completed a $1.6 billion acquisition of Australian startup Eucalyptus, marking a massive expansion into the Asia-Pacific market. The deal has created over 100 millionaires among Eucalyptus's Sydney-based workforce through a $300 million employee share pool.

· 3 min read ·
Share

Key Takeaways

  • US telehealth giant Hims & Hers has completed a $1.6 billion acquisition of Australian startup Eucalyptus, marking a massive expansion into the Asia-Pacific market.
  • The deal has created over 100 millionaires among Eucalyptus's Sydney-based workforce through a $300 million employee share pool.

Mentioned

Eucalyptus company Hims & Hers company HIMS Tim Doyle person Joe Harris person Juniper product Pilot product GLP-1s technology

Key Intelligence

Key Facts

  1. 1Hims & Hers acquired Eucalyptus for a total valuation of $1.6 billion
  2. 2Eucalyptus reported an annual revenue run-rate exceeding $637 million at the time of sale
  3. 3Over 100 employees became millionaires due to an employee share option plan (ESOP)
  4. 4The total value of employee shares, excluding co-founders, is estimated at $300 million
  5. 5Founder Tim Doyle is set to receive a $163 million payout from the transaction
  6. 6The average payout for a Eucalyptus employee is approximately $420,000

Who's Affected

Hims & Hers
companyPositive
Eucalyptus Employees
personPositive
Australian Tech Ecosystem
technologyPositive

Analysis

The acquisition of Eucalyptus by Hims & Hers for $1.6 billion represents more than just a geographic expansion; it is a strategic consolidation of the two most successful players in the direct-to-consumer digital healthcare space. Eucalyptus, founded by Tim Doyle, has long been viewed as the Australian counterpart to Hims & Hers, even drawing direct inspiration from the American firm’s model of destigmatizing sensitive health issues through sleek branding and seamless digital delivery. With Eucalyptus reporting an annual revenue run-rate exceeding $637 million, the acquisition underscores the massive scale achievable in the telehealth sector, particularly when fueled by the explosive demand for GLP-1 weight-loss medications.

The timing of this deal is particularly noteworthy given the global frenzy surrounding GLP-1 agonists like Ozempic and Mounjaro. Eucalyptus’s core brands, Juniper and Pilot, have successfully navigated the complex regulatory and supply chain environments in Australia to provide accessible weight management solutions. By integrating these platforms, Hims & Hers not only gains a dominant foothold in the Asia-Pacific region but also acquires a sophisticated operational blueprint for managing high-demand pharmaceutical categories. This move positions the combined entity as a formidable global challenger to traditional healthcare providers, leveraging a digital-first approach to capture a market that is increasingly moving away from brick-and-mortar clinics.

The acquisition of Eucalyptus by Hims & Hers for $1.6 billion represents more than just a geographic expansion; it is a strategic consolidation of the two most successful players in the direct-to-consumer digital healthcare space.

Beyond the strategic alignment, the deal has sent shockwaves through the Australian technology ecosystem due to its significant wealth creation for employees. The distribution of approximately $300 million in equity to staff—excluding the co-founders—is a rare exit event for the Sydney tech scene. With over 100 employees reaching millionaire status and an average payout of $420,000, the acquisition validates the use of employee share option plans (ESOPs) as a powerful tool for talent retention and wealth distribution in high-growth startups. Former executives like Joe Harris have already noted that such windfalls provide the financial security necessary to seed the next generation of Australian startups, potentially creating a Eucalyptus alumni network similar to the famous PayPal or Skype mafias.

What to Watch

For Hims & Hers, the $1.6 billion price tag reflects a high-conviction bet on the permanence of the telehealth shift. While some analysts have questioned the sustainability of the GLP-1 boom, the diversified nature of Eucalyptus’s portfolio—which includes fertility and men’s health—provides a hedge against category-specific volatility. The challenge now lies in integration. Eucalyptus has operated with a high degree of autonomy and a distinct cultural identity on Sydney’s Clarence Street. Maintaining that entrepreneurial energy while folding into a US-listed giant will be critical for Hims & Hers to realize the full value of the $637 million revenue stream it has just inherited.

Looking forward, this acquisition is likely to trigger further consolidation in the telehealth space as larger players seek to acquire regional leaders to build global platforms. As Tim Doyle noted, the goal is to help more people globally believe in the future of healthcare. That future appears to be one where geography is secondary to platform scale, and where the winners are those who can combine pharmaceutical access with a superior user experience and a robust digital infrastructure.

Timeline

Timeline

  1. Acquisition Announced

  2. Executive Payouts Confirmed

  3. Employee Windfall Reports

Cite This Page

"Hims & Hers Acquires Eucalyptus for $1.6B in Landmark Telehealth Consolidation." SaaS Intelligence Brief, February 24, 2026. https://getsaasbrief.com/story/hims-and-hers-acquires-eucalyptus-1-6-billion-deal

How we covered this story

Every story in our saas coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the saas space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.

Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.